ATHE · Alterity Therapeutics Limited American Depositary Shares
View on chartInsiders & Stakes
| Marks Peter Ashley Director | ▲ Buy | Open Market | 191,340 Shares held | 8/31/2026 | View profile |
Transaction History
| Marks Peter Ashley | ▲ Buy | Open Market | 47,620 | $24K | 8/31/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Alterity CEO speaks at ASX SMIDcaps Conference
Alterity Therapeutics CEO spoke at the ASX SMIDcaps Conference, sharing insights on the company's progress. The appearance highlights ongoing engagement with investors and industry peers. Shares are currently trading near a key support level at $4.50.
Alterity CEO speaks at ASX SMIDcaps Conference. Alterity Therapeutics CEO spoke at the ASX SMIDcaps Conference, sharing insights on the company's progress. The appearance highlights ongoing engagement with investors and industry peers. Shares are currently trading near a key support level at $4.50.